中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

61 records (took 0.031 seconds)

    ASSESSMENT OF HUMAN COMPREHENSION BY AN AUTOMATED AGENT
    32.
    发明申请
    ASSESSMENT OF HUMAN COMPREHENSION BY AN AUTOMATED AGENT 有权

    公开(公告)号：US20210065908A1

    公开(公告)日：2021-03-04

    申请号：US16961266

    申请日：2019-01-11

    Applicant: Nova Southeastern University ,  Emory University

    Inventor： Raymond L. Ownby ,  Amarilis Acevedo ,  Drenna Waldrop-Valverde

    IPC: G16H50/30 ,  G16H10/60 ,  G16H10/20

    Abstract: An electronic processing system agent accesses population health literacy data from a population of at least 100 individuals pertaining to assessed health literacy of members of the population, and demographic data from the population corresponding to age, race, and level of education. The agent collects skills data from the patient corresponding to a set of questions presented to the patient relating to skills needed for understanding therapeutic instructions, as well as personal data relating to the age, race, and level of education of the patient. The agent carries out a polytomous logistic regression using the collected population health literacy data, demographic data, skills data, and personal data in order to assign a health literacy level to the patient corresponding to one of a plurality of groups, and communicates a strategy for the patient corresponding to the assigned health literacy level of the patient, in real time, to enable the patient to have a communication of therapeutic instructions when the patient has responded to the set of questions.

    DATA ADAPTIVE COMPRESSION AND DATA ENCRYPTION USING KRONECKER PRODUCTS
    37.
    发明申请
    DATA ADAPTIVE COMPRESSION AND DATA ENCRYPTION USING KRONECKER PRODUCTS 审中-公开

    公开(公告)号：US20170257649A1

    公开(公告)日：2017-09-07

    申请号：US15505665

    申请日：2015-08-21

    Applicant: NOVA SOUTHEASTERN UNIVERSITY

    Inventor： Abdelkrim BOUROUIHIYA

    IPC: H04N21/2347 ,  H04N19/46

    CPC classification number: H04N21/2347 ,  G06F17/16 ,  H04L9/3066 ,  H04N19/46

    Abstract: Digital files are compressed using a process including Schmidt decompositions of matrices using an algorithm, termed ‘BSD’ herein, which is based on an algebraic method generalizing QR decomposition. Software analyzes an input file and initially identifies a matrix M, with entries within a predefined set of integers, within the file. Next, essential entries are defined, extracted from M, that contain sufficient information to recover Musing BSD. The compressed file includes the essential entries and their positions within M. To achieve an encryption process, software encrypts the pattern matrix that includes the positions of the essential entries of M. To achieve a lossy compression, software identifies essential entries that contain sufficient information to recover an approximation to M for which the quality is determined by an error threshold. For a more efficient lossy compression, software uses singular value decomposition, BSD, and other signal processing of M.

    EPINEPHRINE FINE PARTICLES AND METHODS FOR USE THEREOF FOR TREATMENT OF CONDITIONS RESPONSIVE TO EPINEPHRINE
    39.
    发明申请
    EPINEPHRINE FINE PARTICLES AND METHODS FOR USE THEREOF FOR TREATMENT OF CONDITIONS RESPONSIVE TO EPINEPHRINE 审中-公开
    EPINEPHRINE精细颗粒及其用于治疗对EPINEPHRINE有反应的病症的方法

    公开(公告)号：US20170020827A1

    公开(公告)日：2017-01-26

    申请号：US15288745

    申请日：2016-10-07

    Applicant: NOVA SOUTHEASTERN UNIVERSITY

    Inventor： Mutasem RAWAS-QALAJI ,  Ousama RACHID ,  Keith SIMONS ,  Estelle SIMONS

    IPC: A61K31/137 ,  A61K47/26 ,  A61K9/00 ,  A61K47/12

    CPC classification number: A61K31/137 ,  A61K9/0056 ,  A61K9/006 ,  A61K9/14 ,  A61K47/12 ,  A61K47/26

    Abstract: The invention provides compositions including epinephrine fine particles, including epinephrine nanoparticles or nanocrystals and epinephrine microparticles or microcrystals, and methods for therapeutic use of the compositions for the treatment of conditions responsive to epinephrine such as a cardiac event or an allergic reaction, particularly anaphylaxis. The epinephrine fine particles can be incorporated into orally-disintegrating and fast-disintegrating tablet pharmaceutical formulations and can significantly increase the sublingual bioavailability of epinephrine, and thereby reduce the epinephrine dose required.

    Abstract translation: 本发明提供了包括肾上腺素细颗粒，包括肾上腺素纳米颗粒或纳米晶体和肾上腺素微粒或微晶的组合物，以及用于治疗使用该组合物治疗对肾上腺素（例如心脏事件或过敏反应特别是过敏反应）的病症的方法。 肾上腺素细颗粒可以掺入口腔崩解和快速崩解片剂药物制剂中，并可显着增加肾上腺素的舌下生物利用度，从而降低所需的肾上腺素剂量。

Patent Agency Ranking